China Universal Asset Management Company’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
China Universal Asset Management Company's ADPT Position: Q2 2026 in Review
China Universal Asset Management Company reduced its Adaptive Biotechnologies (ADPT) stake by 12% in Q2 2026, selling an estimated $52.9K and leaving 25,471 shares worth $546K. The position accounts for 0.03% of the portfolio, ranked #257.
China Universal Asset Management Company first reported a position in ADPT in Q3 2022 and has held it in 16 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.
- China Universal Asset Management Company held 25,471 shares of Adaptive Biotechnologies worth $546K as of Q2 2026.
- China Universal Asset Management Company sold 3,454 Adaptive Biotechnologies shares in Q2 2026, an estimated $52.9K.
- Adaptive Biotechnologies made up 0.03% of China Universal Asset Management Company's portfolio in Q2 2026, its #257 holding.
- China Universal Asset Management Company first reported a position in Adaptive Biotechnologies in Q3 2022 and has held it in 16 quarters since.
- 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.